SCHEMBL1347570

SCHEMBL1347570

O=Cc1c(-c2ccc(Cl)cc2)sc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
HSP90AA1 P07900 1/20 0.41
GABRA1 P14867 1/20 0.39
GABRA5 P31644 1/20 0.39
NPSR1 Q6W5P4 3/20 0.37
MAPT P10636 3/20 0.37
HTT P42858 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
NOD2 Q9HC29 1/20 0.37
ATM Q13315 1/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
PMM2 O15305 1/20 0.36
G6PD P11413 1/20 0.36
MPI P34949 1/20 0.36
GPR3 P46089 1/20 0.36
MCL1 Q07820 1/20 0.36
ALDH1A1 P00352 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5792570 0.86 L3MBTL1 (0.49) KDM4EL3MBTL1HSP90AA1TDP1ATM
SCHEMBL9587486 0.84 HSP90AA1 (0.44) KDM4EL3MBTL1HSP90AA1NPSR1MAPT
SCHEMBL14709198 0.84 L3MBTL1 (0.41) KDM4EL3MBTL1HSP90AA1NPSR1MAPT
SCHEMBL8017131 0.80 HSP90AA1 (0.63) KDM4EL3MBTL1HSP90AA1MAPTSMN1; SMN2
SCHEMBL11558775 0.77 KDM4E (0.39) KDM4EL3MBTL1GABRA1GABRA5NPSR1
SCHEMBL28538104 0.75 PTGS2 (0.44) KDM4EL3MBTL1GABRA1GABRA5TDP1
SCHEMBL15200639 0.75 SLC9A1 (0.40) KDM4EL3MBTL1GABRA1GABRA5MAPT
SCHEMBL28521550 0.75 KDM4E (0.41) KDM4EL3MBTL1HSP90AA1GABRA1GABRA5
SCHEMBL28519702 0.75 TDP1 (0.42) KDM4EL3MBTL1HSP90AA1GABRA1GABRA5
SCHEMBL11557192 0.75 GABRA1 (0.53) KDM4EL3MBTL1GABRA1GABRA5MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396337-B1 PREPARATION AND USE OF ZINC-AMIDES UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-13 EP claimed
EP-2396337-A1 PRODUCTION AND USE OF ZINC AMIDES Ludwig-Maximilians-Universität München (DE) 2011-12-21 EP claimed
US-20110288296-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2011-11-24 US claimed
WO-2010092096-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2010-08-19 WO claimed
WO-2006018544-A1 COMPOSITION CONTAINING A THIOPHENIC OR BENZOTHIOPHENIC COMPOUND AND EXHIBITING A PUMP NORA INHIBITING ACTIVITY UNIVERSITE CLAUDE BERNARD LYON I (FR) 2006-02-23 WO claimed
US-9688701-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2017-06-27 US disclosed
US-9688701-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2017-06-27 US disclosed
US-9688701-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2017-06-27 US disclosed
US-20160215000-A1 Production And Use Of Zinc Amides UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-28 US disclosed
US-20160215000-A1 Production And Use Of Zinc Amides UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-28 US disclosed
US-20160215000-A1 Production And Use Of Zinc Amides UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-28 US disclosed
EP-2396337-B1 PREPARATION AND USE OF ZINC-AMIDES UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-13 EP disclosed
US-9334237-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2016-05-10 US disclosed
US-9334237-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2016-05-10 US disclosed
EP-2396337-A1 PRODUCTION AND USE OF ZINC AMIDES Ludwig-Maximilians-Universität München (DE) 2011-12-21 EP disclosed
US-20110288296-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2011-11-24 US disclosed
US-20110288296-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2011-11-24 US disclosed
US-20110288296-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2011-11-24 US disclosed
WO-2010092096-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2010-08-19 WO disclosed
WO-2010092096-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2010-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160215000-A1 Production And Use Of Zinc Amides SCLY, CBR3, SCO2 KDM4E 2931/4885L3MBTL1 1251/4885HSP90AA1 3899/4885
US-20110288296-A1 PRODUCTION AND USE OF ZINC AMIDES GLRX3, SCLY, SFXN1 KDM4E 3350/4885L3MBTL1 1395/4885HSP90AA1 2426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.